EquityProfileReport.com Initiates Watch List on: ONXX, MNKD, AGNC, and BAC

NEW YORK, NY -- (Marketwired) -- 07/02/13 -- Equity Profile Report initiates a NASDAQ Active Stock Watch List adding Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX), MannKind Corp. (NASDAQ: MNKD), American Capital Agency Corp. (NASDAQ: AGNC) and Bank of America Corporation (NYSE: BAC)

Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) closed up their previous session (+51.38%) on 18,526,307 shares traded after they announced submission of their new drug application to the FDA (Food and Drug Administration). They are currently up (+106.98%) from their 52-week low.

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=ONXX&SubId=MW

MannKind Corp. (NASDAQ: MNKD) closed up their previous session (+4.38%) on 6,947,897 shares traded after announcing $160 million of debt financing with affiliated of Deerfield Management Company L.P. MannKind Corp. are currently up (+273.08%) from their 52-week low.

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=MNKD&SubId=MW

American Capital Agency Corp. (NASDAQ: AGNC) closed down their previous session (-0.91%) on 6,410,001 shares traded after recently announcing second quarter dividend on their Series A Preferred Stock. They are down (-37.99%) from the 52-week low

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=AGNC&SubId=MW

Bank of America Corporation (NYSE: BAC) closed up their previous session (+0.54%) on 75,578,023 shares traded after Bank of America announced that they have licensed the SWIFT MyStandards product. Bank of America Corporation is currently up (+87.39%) from its recent 52-week low.

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=BAC&SubId=MW

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Subscribe Here: http://www.Equityprofilereport.com

This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Information, opinions and analysis contained herein are based on sources deemed to be reliable and are subject to change without notice. A third party has hired and paid OTC Report one thousand two hundred and ninety five dollars for the publication and circulation of this news release. Accordingly, certain information included herein may be forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. No representation, expressed or implied, is made as to the accuracy, completeness or correctness. We accept no liability for any losses arising from an investor's reliance on or use of this report. We do not and have not had any ownership interest in said third party of any kind.